As of 2024-12-12, the EV/EBITDA ratio of Valbiotis SA (ALVAL.PA) is -1.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALVAL.PA's latest enterprise value is 8.80 mil EUR. ALVAL.PA's TTM EBITDA according to its financial statements is -7.30 mil EUR. Dividing these 2 quantities gives us the above ALVAL.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 9.1x | 8.4x |
| Forward P/E multiples | 7.8x - 9.4x | 8.6x |
| Fair Price | (2.80) - (3.43) | (3.14) |
| Upside | -308.1% - -354.9% | -333.6% |
| Date | EV/EBITDA |
| 2024-12-09 | -1.27 |
| 2024-12-06 | -1.08 |
| 2024-12-05 | -1.08 |
| 2024-12-04 | -1.18 |
| 2024-12-03 | -1.13 |
| 2024-12-02 | -1.25 |
| 2024-11-29 | -1.32 |
| 2024-11-28 | -0.86 |
| 2024-11-27 | -0.90 |
| 2024-11-26 | -0.93 |
| 2024-11-25 | -0.97 |
| 2024-11-22 | -0.96 |
| 2024-11-21 | -0.97 |
| 2024-11-20 | -1.00 |
| 2024-11-19 | -0.92 |
| 2024-11-18 | -0.99 |
| 2024-11-15 | -1.02 |
| 2024-11-14 | -1.08 |
| 2024-11-13 | -0.84 |
| 2024-11-12 | -0.79 |
| 2024-11-11 | -0.82 |
| 2024-11-08 | -0.85 |
| 2024-11-07 | -0.89 |
| 2024-11-06 | -0.97 |
| 2024-11-05 | -0.98 |
| 2024-11-04 | -1.00 |
| 2024-11-01 | -1.06 |
| 2024-10-31 | -1.06 |
| 2024-10-30 | -1.15 |
| 2024-10-29 | -1.11 |
| 2024-10-28 | -1.14 |
| 2024-10-25 | -1.21 |
| 2024-10-24 | -1.15 |
| 2024-10-23 | -1.17 |
| 2024-10-22 | -1.30 |
| 2024-10-21 | -1.08 |
| 2024-10-18 | -1.11 |
| 2024-10-17 | -1.12 |
| 2024-10-16 | -1.29 |
| 2024-10-15 | -1.04 |
| 2024-10-14 | -1.06 |
| 2024-10-11 | -1.13 |
| 2024-10-10 | -1.15 |
| 2024-10-09 | -1.00 |
| 2024-10-08 | -1.01 |
| 2024-10-07 | -0.99 |
| 2024-10-04 | -0.98 |
| 2024-10-03 | -0.95 |
| 2024-10-02 | -1.04 |
| 2024-10-01 | -1.04 |